Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan D Trinklein

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Plos Genetics|October 3, 2014
Genome-wide discovery of drug-dependent human liver regulatory elementsRobin P Smith, Walter L Eckalbar, Kari M Morrissey, et al.
Mabs|April 5, 2021
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHLHarbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
The Journal of Biological Chemistry|March 16, 2011
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122Daniel R Boutz, Patrick J Collins, Uthra Suresh, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Plos Genetics|June 4, 2011
Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissueFederico Innocenti, Gregory M Cooper, Ian B Stanaway, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Scientific Reports|May 20, 2021
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsKatherine E Harris, Kyle J Lorentsen, Harbani K Malik-Chaudhry, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Oncoimmunology|August 26, 2022
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancerBrian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Plos Genetics|October 3, 2014
Genome-wide discovery of drug-dependent human liver regulatory elementsRobin P Smith, Walter L Eckalbar, Kari M Morrissey, et al.
Mabs|April 5, 2021
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHLHarbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
The Journal of Biological Chemistry|March 16, 2011
Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122Daniel R Boutz, Patrick J Collins, Uthra Suresh, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Plos Genetics|June 4, 2011
Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissueFederico Innocenti, Gregory M Cooper, Ian B Stanaway, et al.
Frontiers in Immunology|May 10, 2018
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific AntibodiesKatherine E Harris, Shelley Force Aldred, Laura M Davison, et al.
Scientific Reports|May 20, 2021
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cellsKatherine E Harris, Kyle J Lorentsen, Harbani K Malik-Chaudhry, et al.
Frontiers in Immunology|January 23, 2019
Multispecific Antibody Development Platform Based on Human Heavy Chain AntibodiesStarlynn C Clarke, Biao Ma, Nathan D Trinklein, et al.
Oncoimmunology|August 26, 2022
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancerBrian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, et al.
Pageof 4